Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies into Clinical Development

Globe Newswire

Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies into Clinical Development

American Association for Cancer Research (AACR)

In vitro modeling of antigen-driven exhaustion in human CAR T cells

American Association for Cancer Research (AACR)

"Development of tumor-restricted IL-12 with antigen-dependent expression and localized IL-12 activity"

American Association for Cancer Research (AACR)

OPB-101: An optimized mesothelin-specific CAR T cell product expressing CD8-targeted IL-2/15 and engineered to resist T cell exhaustion

Globe Newswire

Outpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AACR) Annual Meeting

Society for Immunotherapy of Cancer (SITC)

Protein design and inducible expression allow context-dependent, localized IL-12 activity to enhance solid tumor T cell therapies

Globe Newswire

Outpace Bio to present new data on tumor-restricted IL-12 designed leveraging OutSmart technology to enhance solid tumor T cell therapies at SITC 2023

Cancer Cell

Building smart CAR T cell therapies: The path to overcome current challenges